Active Stocks
Fri Apr 12 2024 15:57:45
  1. Tata Steel share price
  2. 163.50 -1.00%
  1. NTPC share price
  2. 362.00 -0.32%
  1. ITC share price
  2. 430.10 -1.56%
  1. HDFC Bank share price
  2. 1,518.90 -1.10%
  1. State Bank Of India share price
  2. 766.75 -1.57%
Business News/Market/Market Stats/    HDFC Pharma and Healthcare Fund Regular Growth

HDFC Pharma and Healthcare Fund Regular Growth

+
  • Equity
  • Sector - Healthcare
  • Rating N.A.
  • Plan
12.51 +0.02 (0.16%) NAV as on 10 Apr, 2024
  • 5D
  • 1M
  • 6M
  • 1Y
  • 5Y
  • MAX

Key Metrics

  • AUM (in Cr)789.35
  • CAGR 0.00%
  • Exit Load1.00%
  • Expense ratio2.36%
  • CategoryEquity
  • Min Investment100
  • Min SIP100
  • Launch Date2023-10-04

Morning Star Rating N.A.

Risk
Return

Asset Allocation

Holdings As On - 12 April 2024

  • Name
  • Value (Cr)
  • Holding %
View More

Risk & Volitility

  • Alpha 0.00%
  • Beta 0.00
  • Sharpe Ratio0.00
  • Std Deviation 0.00%
  • Tracking Error 0.00%

About Fund

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

 

The HDFC Pharma and Healthcare Fund Regular Growth has an AUM of 789.35 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.36%. The minimum investment in HDFC Pharma and Healthcare Fund Regular Growth is Rs 100 and the minimum SIP is Rs 100.

 

As per morningstar the risk & return rating of the fund are - & - respectively.

 

The top holdings of the fund include Sun Pharmaceutical Industries, Cipla, Lupin & Ajanta Pharmaceuticals.

 

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Chemical Manufacturing.

 

Some of the similar funds are Tata India Pharma & Healthcare Fund Regular Growth, UTI Healthcare Fund Regular Plan Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth. HDFC Pharma and Healthcare Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.

FAQs about HDFC Pharma and Healthcare Fund Regular Growth

According to the morning star rating HDFC Pharma and Healthcare Fund Regular Growth has a & return.
HDFC Pharma and Healthcare Fund Regular Growth is managed by Dhruv Muchhal,Nikhil Mathur.
The expense ratio of HDFC Pharma and Healthcare Fund Regular Growth is 2.36%.
The 5 year annualized return on HDFC Pharma and Healthcare Fund Regular Growth is 0.00% & it has generated 0.00% in the last 1 year.
The minimum investment in HDFC Pharma and Healthcare Fund Regular Growth is 100 Rs.
HDFC Pharma and Healthcare Fund Regular Growth has an AUM of 789.35 crores.
Recommended For You